« FASENRA PEN INJ 30 mg, substance active 1 x 1 ml, CA »

Informations sur le produit destinées aux patients

IMPORTANT NOTES :

  • The information available on this Website is the most recently approved version in your country.
  • Where information available on paper leaflet inside the pack might not be the most recently approved version.